1-6 of 6
Omar Davila
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Busulfan, Melphalan, and Bortezomib Compared to Single Agent High-Dose Melphalan As a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Long Term Follow up of a Novel Conditioning Regimen

Patrick Hagen, MD, Anita D'Souza, MDMS, Parameswaran Hari, MBBS, MD, Omar Davila, Mei-Jie Zhang, David H. Vesole, MD PhD, Scott E. Smith, MD PhD, Tulio E Rodriguez, MD, Patrick J. Stiff, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2023.
https://doi.org/10.1182/blood-2019-124188
Published: 2019
Journal Articles

Primary Plasma Cell Leukemia Outcomes Remain Dismal Despite Novel Agents and Hematopoietic Cell Transplantation

Sagar Patel, MD, Saulius K. Girnius, MD, Binod Dhakal, MBBS, Lohith Gowda, MD, Raphael Fraser, PhD, Omar Davila, Nina D. Shah, MD, Muzaffar H. Qazilbash, MD, Shaji K. Kumar, MD, Anita D'Souza, MDMS, Parameswaran Hari, MBBS, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 266.
https://doi.org/10.1182/blood-2019-127049
Published: 2019
Journal Articles

Breaking the Glass Ceiling of Age in Transplant in Multiple Myeloma

Pashna N. Munshi, MD, Parameswaran Hari, MBBS, MD, David H. Vesole, MD PhD, Artur Jurczyszyn, MD, Jan Zaucha, MD PhD, Omar Davila, Shaji K. Kumar, MD, Nina D. Shah, MD, Muzaffar H. Qazilbash, MD, Anita D'Souza, MDMS
Journal: Blood
Blood (2019) 134 (Supplement_1): 782.
https://doi.org/10.1182/blood-2019-124804
Published: 2019
Journal Articles

Novel Prognostic Scoring System for Autologous Hematopoietic Cell Transplantation (AHCT) in Multiple Myeloma (MM)

Binod Dhakal, MBBS, Raphael Fraser, PhD, Zhubin Gahvari, MD, Aric C. Hall, MD, Natalie Scott Callander, MD, Saurabh Chhabra, MD, Omar Davila, Shaji K. Kumar, MD, Nina D. Shah, MD, Muzaffar H. Qazilbash, MD, Anita D'Souza, MDMS, Parameswaran Hari, MBBS, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 783.
https://doi.org/10.1182/blood-2019-126646
Published: 2019
Journal Articles

Revised-International Staging System (R-ISS) Is Independently Predictive and Prognostic for Early Relapse (<24 months) after Upfront Autologous Hematopoietic Cell Transplantation (AHCT) for Newly Diagnosed Multiple Myeloma (MM

Sathish Kumar, Anita D'Souza, MBBS, Emma C. Scott, MD, Raphael Fraser, Omar Davila, Cristina J. Gasparetto, MD, Shaji K Kumar, MD, Tomer M Mark, MDMSc, Yago Nieto, MD PhD, Parameswaran Hari, MD MRCP, MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 2024.
https://doi.org/10.1182/blood.V130.Suppl_1.2024.2024
Published: 2017
Journal Articles

A Comparison between 3 Staging Systems in Multiple Myeloma Using the Center for International Blood and Marrow Transplant Research (CIBMTR) Database

Emma Scott, Parameswaran Hari, MD MRCP, MS, Sathish Kumar, Raphael Fraser, Omar Davila, Yago Nieto, MD PhD, Tomer M Mark, MDMSc, Shaji K Kumar, MD, Cristina J. Gasparetto, MD, Anita D'Souza, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 3042.
https://doi.org/10.1182/blood.V130.Suppl_1.3042.3042
Published: 2017